vs

Side-by-side financial comparison of agilon health, inc. (AGL) and Brookfield Infrastructure Corp (BIPC). Click either name above to swap in a different company.

agilon health, inc. is the larger business by last-quarter revenue ($1.6B vs $866.0M, roughly 1.8× Brookfield Infrastructure Corp). agilon health, inc. runs the higher net margin — -12.0% vs -35.7%, a 23.6% gap on every dollar of revenue. On growth, agilon health, inc. posted the faster year-over-year revenue change (3.1% vs -4.6%).

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

Brookfield Infrastructure Partners L.P. is a publicly traded limited partnership with corporate headquarters in Toronto, Canada, that engages in the acquisition and management of infrastructure assets on a global basis.

AGL vs BIPC — Head-to-Head

Bigger by revenue
AGL
AGL
1.8× larger
AGL
$1.6B
$866.0M
BIPC
Growing faster (revenue YoY)
AGL
AGL
+7.7% gap
AGL
3.1%
-4.6%
BIPC
Higher net margin
AGL
AGL
23.6% more per $
AGL
-12.0%
-35.7%
BIPC

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
AGL
AGL
BIPC
BIPC
Revenue
$1.6B
$866.0M
Net Profit
$-188.9M
$-309.0M
Gross Margin
65.0%
Operating Margin
-12.3%
62.7%
Net Margin
-12.0%
-35.7%
Revenue YoY
3.1%
-4.6%
Net Profit YoY
-78.5%
-148.1%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGL
AGL
BIPC
BIPC
Q4 25
$1.6B
Q3 25
$1.4B
Q2 25
$1.4B
$866.0M
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
$908.0M
Q1 24
$1.6B
Net Profit
AGL
AGL
BIPC
BIPC
Q4 25
$-188.9M
Q3 25
$-110.2M
Q2 25
$-104.4M
$-309.0M
Q1 25
$12.1M
Q4 24
$-105.8M
Q3 24
$-117.6M
Q2 24
$-30.7M
$643.0M
Q1 24
$-6.1M
Gross Margin
AGL
AGL
BIPC
BIPC
Q4 25
Q3 25
Q2 25
65.0%
Q1 25
Q4 24
Q3 24
Q2 24
63.8%
Q1 24
Operating Margin
AGL
AGL
BIPC
BIPC
Q4 25
-12.3%
Q3 25
-9.1%
Q2 25
-8.3%
62.7%
Q1 25
-1.4%
Q4 24
-7.1%
Q3 24
-9.2%
Q2 24
-2.9%
61.9%
Q1 24
-0.4%
Net Margin
AGL
AGL
BIPC
BIPC
Q4 25
-12.0%
Q3 25
-7.7%
Q2 25
-7.5%
-35.7%
Q1 25
0.8%
Q4 24
-6.9%
Q3 24
-8.1%
Q2 24
-2.1%
70.8%
Q1 24
-0.4%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGL
AGL
BIPC
BIPC
Cash + ST InvestmentsLiquidity on hand
$173.7M
$1.2B
Total DebtLower is stronger
$35.0M
Stockholders' EquityBook value
$126.7M
$2.2B
Total Assets
$1.3B
$23.9B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGL
AGL
BIPC
BIPC
Q4 25
$173.7M
Q3 25
$171.7M
Q2 25
$171.4M
$1.2B
Q1 25
$136.9M
Q4 24
$188.2M
Q3 24
$148.2M
Q2 24
$109.5M
$466.0M
Q1 24
$111.7M
Total Debt
AGL
AGL
BIPC
BIPC
Q4 25
$35.0M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGL
AGL
BIPC
BIPC
Q4 25
$126.7M
Q3 25
$306.1M
Q2 25
$408.9M
$2.2B
Q1 25
$500.3M
Q4 24
$471.0M
Q3 24
$574.9M
Q2 24
$676.6M
$3.5B
Q1 24
$689.3M
Total Assets
AGL
AGL
BIPC
BIPC
Q4 25
$1.3B
Q3 25
$1.6B
Q2 25
$1.7B
$23.9B
Q1 25
$1.9B
Q4 24
$1.7B
Q3 24
$2.1B
Q2 24
$2.2B
$23.7B
Q1 24
$2.3B
Debt / Equity
AGL
AGL
BIPC
BIPC
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGL
AGL
BIPC
BIPC
Operating Cash FlowLast quarter
$-20.5M
$478.0M
Free Cash FlowOCF − Capex
$-23.5M
FCF MarginFCF / Revenue
-1.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-119.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGL
AGL
BIPC
BIPC
Q4 25
$-20.5M
Q3 25
$-18.2M
Q2 25
$-35.1M
$478.0M
Q1 25
$-32.0M
Q4 24
$16.4M
Q3 24
$-7.7M
Q2 24
$-18.7M
$511.0M
Q1 24
$-47.8M
Free Cash Flow
AGL
AGL
BIPC
BIPC
Q4 25
$-23.5M
Q3 25
$-21.3M
Q2 25
$-38.3M
Q1 25
$-35.8M
Q4 24
$13.2M
Q3 24
$-11.2M
Q2 24
$-22.0M
Q1 24
$-50.9M
FCF Margin
AGL
AGL
BIPC
BIPC
Q4 25
-1.5%
Q3 25
-1.5%
Q2 25
-2.7%
Q1 25
-2.3%
Q4 24
0.9%
Q3 24
-0.8%
Q2 24
-1.5%
Q1 24
-3.2%
Capex Intensity
AGL
AGL
BIPC
BIPC
Q4 25
0.2%
Q3 25
0.2%
Q2 25
0.2%
Q1 25
0.3%
Q4 24
0.2%
Q3 24
0.2%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
AGL
AGL
BIPC
BIPC
Q4 25
Q3 25
Q2 25
Q1 25
-2.64×
Q4 24
Q3 24
Q2 24
0.79×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGL
AGL

Medical Services$1.6B100%
Other Operating$2.5M0%

BIPC
BIPC

Segment breakdown not available.

Related Comparisons